Peer Review History

Original SubmissionDecember 24, 2024
Decision Letter - Harapan Harapan, Editor

PONE-D-24-59480Spatial patterns and clustering of dengue incidence in Mexico: Analysis of Moran's index across 2,471 municipalities from 2022 to 2024PLOS ONE

Dear Dr. Murillo-Zamora,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Harapan Harapan, MD, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that Figure 1, 3, Supplementary data 1 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure 1, 3, Supplementary data 1 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

3. Please include a caption for figure 2.

4. Please upload a copy of Figure 2 to which you refer in your text on page 7, 9. If the figure is no longer to be included as part of the submission please remove all reference to it within the text.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: [General Comments]

This manuscript presents an important analysis of dengue transmission dynamics in Mexico, offering valuable epidemiological insights. The spatial and statistical methods applied are appropriate, and the results provide actionable information for disease control. However, certain areas require improvement in clarity, methodological transparency, and discussion depth.

[Specific Comments] – Major

Comment 1: Kindly expand the description of spatial clustering methods. The rationale for using a fixed kNN of 5 should be justified in the context of Mexico’s geographic and epidemiological diversity.

Comment 2: The authors have documented a shift in high-incidence areas from southern and central regions to the southeast and Pacific coast. I suggest you explore more potential drivers such as climate variability, vector control measures, or urbanization patterns.

Comment 3: More discussion is needed regarding how these spatial trends compare with previous dengue outbreaks in Mexico and globally.

Comment 4: The transition from DENV-2 dominance in 2022 to DENV-3 prevalence in 2023-2024 is an important finding. The authors should please discuss possible virological, ecological, or immunological factors influencing this shift.

Comment 5: Building on Comment 4, the authors should consider specific potential public health implications of serotype shifts, including changes in disease severity or vaccine effectiveness.

Comment 6: The discussion on intervention strategies remains general. The authors should kindly provide specific recommendations for vector control, early warning systems, or targeted public health campaigns in the identified high-risk regions.

[Specific Comments] – Minor

Comment 7: Clarify how missing data were handled in dengue incidence reporting.

Comment 8: Please kindly clarify whether population estimates were interpolated for 2023 and 2024 or based on projections.

Comment 9: Report confidence intervals for incidence rates where applicable.

Comment 10: Provide effect sizes alongside p-values in statistical comparisons.

Reviewer #2: A review report of the manuscript entitled “Spatial patterns and clustering of dengue incidence in Mexico: Analysis of Moran's index across 2,471 municipalities from 2022 to 2024”

- (page 9, line 2) in the beginning of the abstract part, what is known or contextual background of this study should be provided.

- (page 9, line 3) the source of the dengue case data is not mentioned. Was the data obtained from health records, a surveillance system, or another source? Please specify if the data is from a national surveillance database or other repositories.

- (page 10, introduction) although the serotype dynamics are addressed in the abstract, the introduction does not mention how the serotypes (e.g., DENV-1 to DENV-4) influence spatial and temporal patterns. Kindly explain the relevance of serotype shifts or dominance to dengue epidemiology.

- (page 10, line 27) the role of climate (e.g., temperature, rainfall) in driving dengue transmission is not mentioned. These are key factors influencing vector activity and virus replication rates and should be briefly noted. Please mention how temperature, rainfall, and vegetation influence vector ecology and dengue transmission. For instance, "Dengue transmission is influenced by climatic factors such as temperature and rainfall, which directly affect mosquito breeding, survival, and virus replication." This can be cited from a study by Dhewantara et al. entitled “Decline of notified dengue infections in Indonesia in 2017: Discussion of the possible determinants.”

- (page 11, line 47) a clear research hypothesis is missing. Please include a statement of your hypothesis in the end of your introduction.

- (page 11, line 58) the method for addressing missing or incomplete case data is not discussed. For instance, were municipalities with incomplete case or population data excluded? Was imputation performed for missing weekly case counts?

- (page 11, line 69) the GIS software or package used for mapping is not mentioned. Was mapping performed in R (e.g., using sf, tmap, or ggplot2), QGIS, or ArcGIS?

- (page 19, line 180) the discussion could benefit from comparisons with other regions where similar spatial or temporal dengue patterns have been observed. For example, how do the patterns in Mexico compare with other endemic regions like Brazil, Southeast Asia, or the Caribbean?

- (page 10, lines 26-28) this statement “This can be attributed to various factors, including human behavior, and environmental conditions (ecological, entomological, infrastructural, and social)” will be stronger if it’s supported by another relevant study. For example, a study by Musa et al. entitled “Revitalizing the state of primary healthcare towards achieving universal health coverage in conflict affected fragile northeastern Nigeria: Challenges, strategies and way forward.”

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 1

REVIEWER 1

General Comment

COMMENT 1: This manuscript presents an important analysis of dengue transmission dynamics in Mexico, offering valuable epidemiological insights. The spatial and statistical methods applied are appropriate, and the results provide actionable information for disease control. However, certain areas require improvement in clarity, methodological transparency, and discussion depth.

RESPONSE (R): We sincerely thank Reviewer 1 for the insightful comments and positive feedback on our manuscript. We appreciate your recognition of the significance of our analysis and its contribution to understanding the dynamics of dengue transmission in Mexico. In response to your suggestions, we have addressed the areas requiring improvement.

[Specific Comments] – Major

COMMENT 2: Kindly expand the description of spatial clustering methods. The rationale for using a fixed kNN of 5 should be justified in the context of Mexico’s geographic and epidemiological diversity.

R: We agree with the suggested specification. This choice ensured that each region is compared with a consistent number of neighboring areas, despite variations in population density and transmission patterns, thereby enhancing the reliability of identifying spatial clusters across diverse settings. This is now included in the new version of the manuscript submitted for revision (please refer to lines 95-99).

COMMENT 3: The authors have documented a shift in high-incidence areas from southern and central regions to the southeast and Pacific coast. I suggest you explore more potential drivers such as climate variability, vector control measures, or urbanization patterns.

R: In agreement with Reviewer 1's suggestion, we have expanded the discussion on potential drivers in the revised manuscript (please refer to lines 233-239).

COMMENT 4: More discussion is needed regarding how these spatial trends compare with previous dengue outbreaks in Mexico and globally.

R: In the new version of the manuscript submitted for revision, a broader discussion of the spatial trends of dengue in Mexico and other countries and regions is included (please refer to lines 212-232).

COMMENT 5: The transition from DENV-2 dominance in 2022 to DENV-3 prevalence in 2023-2024 is an important finding. The authors should please discuss possible virological, ecological, or immunological factors influencing this shift.

R: This shift may be linked to the reemergence of DENV-3, as its circulation had not been documented in the country for over a decade. This, along with other potential drivers, is discussed in the revised manuscript (please refer to lines 242-247).

COMMENT 6: Building on Comment 5, the authors should consider specific potential public health implications of serotype shifts, including changes in disease severity or vaccine effectiveness.

R: As suggested, we addressed how these shifts can influence disease severity, particularly in populations with prior heterotypic immunity, and impact vaccine effectiveness. This is now included in the new version of the manuscript submitted for revision (please refer to lines 248-254).

COMMENT 6: The discussion on intervention strategies remains general. The authors should kindly provide specific recommendations for vector control, early warning systems, or targeted public health campaigns in the identified high-risk regions.

R: We agree with Reviewer 1 and have incorporated a broader discussion on intervention strategies in the revised manuscript submitted for revision (please refer to lines 273–295).

[Specific Comments] – Minor

COMMENT 7: Clarify how missing data were handled in dengue incidence reporting.

R: Municipalities with missing incidence data were excluded. To facilitate spatial comparisons, municipalities were categorized into quintiles based on the computed rates. This is now included in the new version of the manuscript submitted for revision (please refer to lines 65-67).

COMMENT 8: Please kindly clarify whether population estimates were interpolated for 2023 and 2024 or based on projections.

R: Population data were obtained from publicly available projections (2021-2040) by the National Population Council of Mexico. This is now included in the new version of the manuscript submitted for revision (please refer to lines 75-78).

COMMENT 9: Report confidence intervals for incidence rates where applicable.

R: We appreciate your suggestion regarding the inclusion of confidence intervals (CIs) for the municipality-specific dengue rates. In this study, the rates were calculated using population-level epidemiological surveillance data, meaning they represent complete values rather than sample-based estimates subject to statistical variability.

COMMENT 10: Provide effect sizes alongside p-values in statistical comparisons.

R: We agree with Reviewer 1. The magnitude of Moran’s I represents the extent of spatial autocorrelation, with values approaching +1 indicating strong clustering and those nearing -1 signifying pronounced dispersion. This is now specified in the new version of the manuscript submitted for revision (please refer to lines 149-151).

REVIEWER 2

General Comment

COMMENT 1: A review report of the manuscript entitled “Spatial patterns and clustering of dengue incidence in Mexico: Analysis of Moran's index across 2,471 municipalities from 2022 to 2024”.

Response (R): We sincerely appreciate the thoughtful observations and valuable suggestions provided in the review report. We have carefully considered all comments and implemented the necessary revisions to improve the clarity, rigor, and overall quality of the manuscript.

Specific Comments

COMMENT 2: (page 9, line 2) in the beginning of the abstract part, what is known, or contextual background of this study should be provided.

R: As suggested by Reviewer 2, a brief contextual background has been included in the new version of the manuscript submitted for revision (please refer to lines 30-34).

COMMENT 3: (page 9, line 3) the source of the dengue case data is not mentioned. Was the data obtained from health records, a surveillance system, or another source? Please specify if the data is from a national surveillance database or other repositories.

R: We apologize for the previous omission. The data were obtained through the normative epidemiological surveillance system for vector-borne diseases. This is now specified in the new version of the manuscript submitted for revision (please refer to lines 66-67).

COMMENT 4: (page 10, introduction) although the serotype dynamics are addressed in the abstract, the introduction does not mention how the serotypes (e.g., DENV-1 to DENV-4) influence spatial and temporal patterns. Kindly explain the relevance of serotype shifts or dominance to dengue epidemiology.

R: We agree with Reviewer 2, and the revised Introduction now includes a brief description of the spatial and temporal patterns of DENV serotypes, along with the relevance of serotype shifts to dengue epidemiology (please refer to lines 41-43).

COMMENT 5: (page 10, line 27) the role of climate (e.g., temperature, rainfall) in driving dengue transmission is not mentioned. These are key factors influencing vector activity and virus replication rates and should be briefly noted. Please mention how temperature, rainfall, and vegetation influence vector ecology and dengue transmission. For instance, "Dengue transmission is influenced by climatic factors such as temperature and rainfall, which directly affect mosquito breeding, survival, and virus replication." This can be cited from a study by Dhewantara et al. entitled “Decline of notified dengue infections in Indonesia in 2017: Discussion of the possible determinants.”

R: We thank Reviewer 2 for the suggested reference, which the research group found pertinent and has now been included in the revised manuscript. Additionally, a brief description of the role of climatic factors in dengue epidemiology has been added (please refer to lines 30-34).

COMMENT 6: (page 11, line 47) a clear research hypothesis is missing. Please include a statement of your hypothesis in the end of your introduction.

R: We hypothesized that dengue transmission hotspots are not randomly distributed but follow spatial patterns influenced by disease dynamics over time. Specifically, we expect that municipalities with historically high dengue incidence will exhibit persistent transmission, with spatial clustering reflecting underlying transmission trends. This is now included in the new version of the manuscript submitted for revision (please refer to lines 58-61). The hypothesis is discussed in lines 197-200 and 209-211.

COMMENT 7: (page 11, line 58) the method for addressing missing or incomplete case data is not discussed. For instance, were municipalities with incomplete case or population data excluded? Was imputation performed for missing weekly case counts?

R: No imputations were performed, and municipalities with missing incidence data were excluded. This is now stated in the new version of the manuscript submitted for revision (please refer to lines 76-78).

COMMENT 8: (page 11, line 69) the GIS software or package used for mapping is not mentioned. Was mapping performed in R (e.g., using sf, tmap, or ggplot2), QGIS, or ArcGIS?

R: Mapping was performed in R 4.4.1 using the ggplot2 package. This is now stated in the new version of the manuscript submitted for revision (please refer to line 80-84).

COMMENT 9: (page 19, line 180) the discussion could benefit from comparisons with other regions where similar spatial or temporal dengue patterns have been observed. For example, how do the patterns in Mexico compare with other endemic regions like Brazil, Southeast Asia, or the Caribbean?

R: A comparison of the observed patterns with those in other regions has been included in the revised version of the manuscript submitted for review (please refer to lines 212–239).

COMMENT 10: (page 10, lines 26-28) this statement “This can be attributed to various factors, including human behavior, and environmental conditions (ecological, entomological, infrastructural, and social)” will be stronger if it’s supported by another relevant study. For example, a study by Musa et al. entitled “Revitalizing the state of primary healthcare towards achieving universal health coverage in conflict affected fragile northeastern Nigeria: Challenges, strategies and way forward.”

R: We agree with Reviewer 2 on the importance of supporting the statement. After carefully analyzing the suggested reference, we have included it in the revised version of the manuscript submitted for review (please refer to line 31).

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Journal Requirements

When submitting your revision, we need you to address these additional requirements.

COMMENT 1: Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response (R): I appreciate the observation, and the relevant modifications were made according to the guidelines.

COMMENT 2: We note that Figure 1, 3, Supplementary data 1 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure 1, 3, Supplementary data 1 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalma

Decision Letter - Harapan Harapan, Editor

Spatial patterns and clustering of dengue incidence in Mexico: Analysis of Moran's index across 2,471 municipalities from 2022 to 2024

PONE-D-24-59480R1

Dear Dr. Murillo-Zamora,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Harapan Harapan, MD, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: The objective of this study was to analyze spatial and temporal patterns of dengue incidence across municipalities in Mexico from 2022 to 2024. Though I do hope further studies could explore the spatial regression, but the overall results presented are sufficient to answer the research question. I have no further concerns over the manuscript.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Oluwafemi Balogun, MBBS, MPH

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Harapan Harapan, Editor

PONE-D-24-59480R1

PLOS ONE

Dear Dr. Murillo-Zamora,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Harapan Harapan

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .